These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6181094)

  • 1. Studies on the thymus from patients with multiple sclerosis and myasthenia gravis.
    Trotter JL; Ferguson TF; Garvey WF
    J Neuroimmunol; 1982 Oct; 3(2):99-111. PubMed ID: 6181094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic lymphocytes in myasthenia gravis.
    Birnbaum G; Tsairis P
    Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis.
    Aarli JA; Heimann P; Matre R; Thunold S; Tönder O
    J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):29-34. PubMed ID: 310870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
    Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
    J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy.
    Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown.
    Chilosi M; Iannucci A; Fiore-Donati L; Tridente G; Pampanin M; Pizzolo G; Ritter M; Bofill M; Janossy G
    J Neuroimmunol; 1986 May; 11(3):191-204. PubMed ID: 3514666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked increase in CD44-highly positive cells in hyperplastic thymuses from patients with Myasthenia gravis.
    Utsugisawa K; Nagane Y; Tohgi H
    Muscle Nerve; 2000 Apr; 23(4):507-13. PubMed ID: 10716760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thymic lymphoid hyperplasia of myasthenia gravis patients: correlation with clinical features and efficacy of thymectomy].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Tamura K; Suzuki T; Kametani Y; Kataoka D; Nakata H; Itoyama S
    Kyobu Geka; 1995 Jun; 48(6):447-51. PubMed ID: 7602854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoreactivity between lymphocytes and thymus cells in myasthenia gravis.
    Opelz G; Keesey J; Glovsky MM; Gale RP
    Arch Neurol; 1978 Jul; 35(7):413-5. PubMed ID: 149529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinical features and immune responses after extended thymectomy for myasthenia gravis in patients with atrophic versus hyperplastic thymus.
    Chen Z; Luo H; Peng Y; Cai L; Zhang J; Su C; Zou J
    Ann Thorac Surg; 2011 Jan; 91(1):212-8. PubMed ID: 21172515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific T-cell activation in hyperplastic thymus in myasthenia gravis.
    Utsugisawa K; Nagane Y; Suzuki S; Kondoh R
    Muscle Nerve; 2007 Jul; 36(1):100-3. PubMed ID: 17471566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thymus in myasthenia gravis. Evidence for altered cell populations.
    Abdou NI; Lisak RP; Zweiman B; Abrahamsohn I; Penn AS
    N Engl J Med; 1974 Dec; 291(24):1271-5. PubMed ID: 4279335
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of thymus cells in hyperplastic thymuses in patients with myasthenia gravis and ulcerative colitis with monoclonal antibodies.
    Aiso S; Yoshida T; Watanabe M; Hibi T; Asakura H; Tsuchiya M; Tsuru S
    J Clin Lab Immunol; 1984 Mar; 13(3):137-9. PubMed ID: 6609240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKT-associated markers and perforin in hyperplastic thymuses from patients with Myasthenia gravis.
    Nagane Y; Utsugisawa K; Obara D; Tohgi H
    Muscle Nerve; 2001 Oct; 24(10):1359-64. PubMed ID: 11562917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered intrathymic T-cell repertoire in human myasthenia gravis.
    Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S
    Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
    Ichikawa Y; Shimizu H; Yoshida M; Arimori S
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The morphological and clinico-immunological characteristics of 2 types of myasthenia].
    Zaĭrat'iants OV; Vetshev PS; Ippolitov IKh; Shkrob LO; Belokrinitskiĭ DV; Khodzhaev ZSh; Radenska-Lopovok SG
    Arkh Patol; 1991; 53(8):22-7. PubMed ID: 1953371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.
    Namba T; Nakata Y; Grob D
    Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte subpopulations in non-neoplastic thymus from myasthenia gravis patients.
    Piantelli M; Musiani P; Lauriola L; Carbone A; Tonali P; Dina MA
    Clin Exp Immunol; 1980 Jul; 41(1):19-24. PubMed ID: 6969152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.